Delivery Order SPE2DB22D3011-SPE2DB25FP9NB

Award Date 2/26/25
Potential Completion Date 2/27/25
Potential Value $5.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,935.55, is for the delivery of PEDIARIX 0.5 ML SYRINGE 0.5ML and has an ultimate completion date of October 17, 2024. The contract type is Delivery Order with a Firm Fixed Price pricing structure. This award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, valued at $3,654.30, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of PEDIARIX 0.5 ML SYRINGE 0.5ML. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of December 4, 2024. This award is not associated with a set-aside program and is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA...
This federal contract award, issued by the Defense Logistics Agency (DLA), was granted to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,414.11, is for the delivery of PEDIARIX 0.5 ML SYRINGE 0.5ML medical supplies. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of November 24, 2023. The award is associated with a larger Indefinite Delivery Contract (IDC)...
The federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,249.38, is for the delivery of PEDIARIX 0.5 ML SYRINGE 0.5ML, a pharmaceutical product. This is a firm fixed-price delivery order contract with an ultimate completion date of April 19, 2023. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of PEDIARIX 0.5 ML SYRINGE 0.5ML. The $6,375.00 firm-fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,975.91, is a delivery order for the supply of PEDIARIX 0.5 ML SYRINGE 0.5ML medical products. The contract has an ultimate completion date of February 10, 2025 and is a firm fixed-price contract. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and...
This federal contract award, valued at $5,724.15, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of PEDIARIX 0.5 ML SYRINGE 0.5ML, a pediatric vaccine, with a completion date of January 18, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,453.58, is for the delivery of PEDIARIX 0.5 ML SYRINGE 0.S0ML medical supplies. This award is a delivery order under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which is valued at $999,999,999 and runs through November...
This federal contract award, valued at $27,541.17, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of PEDIARIX 0.5 ML SYRINGE 0.5ML, a medical supply item, with a completion date of May 15, 2024. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,154.00, is for the delivery of the PEDIARIX 0.5 ML SYRINGE 0.5ML pharmaceutical product. The contract has an ultimate completion date of January 27, 2025 and is structured as a firm fixed-price delivery order. This contract award is not designated with any set-aside requirements, indicating...
  • SPE2DB22D3011
    Indefinite Delivery Contract
  • SPE2DB22D3011-SPE2DB25FP9NB
    Delivery Order

This federal contract award, valued at $5,721.03, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of PEDIARIX 0.5 ML SYRINGE 0.5ML. The contract is a Firm Fixed Price Delivery Order with a completion date of February 27, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 5/28/25, 10:59 AM